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Differential host susceptibility and 
bacterial virulence factors driving 
Klebsiella liver abscess  
in an ethnically diverse population
I. Russel Lee1, James S. Molton2,3, Kelly L. Wyres4,5, Claire Gorrie4,5, Jocelyn Wong1, 
Chu Han Hoh1, Jeanette Teo6, Shirin Kalimuddin7, David C. Lye3,8, Sophia Archuleta2,3, 
Kathryn E. Holt4,5 & Yunn-Hwen Gan1
Hypervirulent Klebsiella pneumoniae is an emerging cause of community-acquired pyogenic liver 
abscess. First described in Asia, it is now increasingly recognized in Western countries, commonly 
afflicting those with Asian descent. This raises the question of genetic predisposition versus geospecific 
strain acquisition. We leveraged on the Antibiotics for Klebsiella Liver Abscess Syndrome Study 
(A-KLASS) clinical trial ongoing in ethnically diverse Singapore, to prospectively examine the profiles 
of 70 patients together with their isolates’ genotypic and phenotypic characteristics. The majority of 
isolates belonged to capsule type K1, a genetically homogenous group corresponding to sequence-
type 23. The remaining K2, K5, K16, K28, K57 and K63 isolates as well as two novel cps isolates were 
genetically heterogeneous. K1 isolates carried higher frequencies of virulence-associated genes 
including rmpA (regulator of mucoid phenotype A), kfu (Klebsiella ferric uptake transporter), iuc 
(aerobactin), iro (salmochelin) and irp (yersiniabactin) than non-K1 isolates. The Chinese in our patient 
cohort, mostly non-diabetic, had higher prevalence of K1 infection than the predominantly diabetic 
non-Chinese (Malays, Indian and Caucasian). This differential susceptibility to different capsule types 
among the various ethnic groups suggests patterns of transmission (e.g. environmental source, familial 
transmission) and/or genetic predisposition unique to each race despite being in the same geographical 
location.
A new, hypervirulent variant of Klebsiella pneumoniae (hvKP) has been increasingly described in the last two dec-
ades. Combinations of clinical as well as bacterial genotypic and phenotypic features distinguish this variant from 
the “classic” opportunistic K. pneumoniae. The first is its ability to cause life-threatening disease in healthy indi-
viduals, although diabetes mellitus is a risk factor1–4. Unique invasive syndromes include community-acquired 
monomicrobial pyogenic liver abscess, and a propensity for metastatic spread to unusual distant sites including 
the eye, brain and lung2,4,5. The second is its ability to more efficiently acquire iron, and enhanced ability to pro-
duce the polysaccharide capsule that typically results in the hypermucoviscous phenotype5–8. At least 79 capsule 
types of K. pneumoniae exist9. For hvKP, eight types have been described to date: K1, K2, K5, K16, K20, K54, 
K57 and KN11,3,10,11. The vast majority of hvKP that cause Klebsiella liver abscess (KLA) are K1 or K2 capsule 
types3,4,12. Through multi-locus sequence typing (MLST), sequence-type (ST) 23 was found to be strongly asso-
ciated with capsule type K1, while ST25, ST86, ST375 and ST380 have been associated with capsule type K213–16.
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Although the route of hvKP entry into humans has not been established, the gastrointestinal tract appears 
to be the dominant site of colonization. K. pneumoniae isolated from healthy carriers has identical pulsed-field 
gel electrophoresis profile as well as similar virulence-associated genes and median lethal dose values in mouse 
lethality assays as hvKP isolated from patients with liver abscess17. When mice were orally infected with hvKP, 
four distinct stages were observed to develop sequentially: intestinal colonization, extraintestinal dissemination, 
hepatic replication and septic metastasis18.
While hvKP was first discovered in the Asia Pacific Rim (e.g. Taiwan) in the mid-1980s19, it is now increasingly 
recognized in Western countries (e.g. North America)15,20,21. However, most cases acquired in Western countries 
commonly occur among Asians1,2. Inevitably, travel to the Asia Pacific Rim or exposure to people from that region 
is assumed to increase the risk of KLA. Indeed, hvKP strain acquisition resulting in colonization and subsequent 
infection from international travel has been documented22,23. Nonetheless, this risk factor is unable to account 
for all the KLA cases occurring outside of Asia15,20. This raises the question about the importance of host genetic 
susceptibility (Asians, particularly of Chinese ethnicity) versus geographically defined pathogen exposure and 
acquisition (Asia Pacific Rim) in driving the epidemiology of KLA. Research on hvKP is most extensive in Asia. 
Various associations of patient clinical features and bacterial molecular characteristics influencing KLA develop-
ment have been reported from Taiwan, China, Hong Kong and Korea3,4,16,24,25. However, these clinical studies of 
large case series were almost exclusively conducted on ethnically homogenous populations. Therefore, the issue 
of genetic predisposition versus geospecific strain acquisition remains unresolved.
We leveraged on a prospective multi-center randomized clinical trial [Antibiotics for Klebsiella Liver Abscess 
Syndrome Study (A-KLASS)] ongoing in Singapore, where KLA is now the leading cause of liver abscess26. 
Singapore is a multiracial and multicultural country, consisting of 76.2% Chinese, 15% Malay, 7.4% Indian, and 
1.4% other races27. Information on the prevalence of diabetes mellitus among the various ethnic groups is also 
available: 17.2% of Indians, 16.6% of Malays and 9.7% of Chinese have underlying diabetes28. In order to under-
stand what drives the development of KLA, we collected bacterial isolates from 70 consecutive A-KLASS par-
ticipants of all four ethnic groups, with information on their clinical profile and parameters. We explored the 
relationship between clonal distribution and virulence profiles of KLA isolates with the corresponding patient 
demographics and host susceptibility factors.
Results
KLA patient characteristics. Seventy participants were recruited between 7 March 2013 and 19 October 
2015. Patient characteristics are summarized in Table 1. The mean age was 59.8 ± 11.9 years. Eighty percent 
(56/70) were male. Seventy-six percent (53/70) were Chinese, 21.4% (15/70) Malay, 1.4% (1/70) Indian, and 
Variable Mean / Frequency
Demographics
 Age, mean years ± SD (range) 59.8 ± 11.9 (30–86)
 Male gender 56/70 (80.0%)
Ethnicity
 Chinese 53/70 (75.7%)
 Malay 15/70 (21.4%)
 Indian 1/70 (1.4%)
 Others 1/70 (1.4%)
Underlying disease
 Type 2 diabetes mellitus 33/70 (47.1%)
 Cardiovascular disease 29/70 (41.4%)
 Hypertension 24/70 (34.3%)
 Hyperlipidemia 22/70 (31.4%)
 Gastrointestinal tract disease 11/70 (15.7%)
 Anaemia 10/70 (14.3%)
 Biliary tract disease 9/70 (12.9%)
 Neurologic disease 7/70 (10%)
 Pulmonary disease 5/70 (7.1%)
 Chronic kidney disease 5/70 (7.1%)
 Hepatic disease 5/70 (7.1%)
 Malignancy 4/70 (5.7%)
 Hepatitis B 4/70 (5.7%)
 Gallstones 2/70 (2.9%)
Radiological imaging
 Size of liver abscess, mean mm ± SD (range) 57.6 ± 30.6 (10–140)
 Multiple liver abscesses 28/70 (40.0%)
Table 1.  KLA patient characteristics (n = 70).
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1.4% (1/70) Caucasian. Compared to Singapore’s ethnic distribution, Malays were slightly over-represented in 
our patient cohort with Indians under-represented, whereas Chinese and other races were appropriately repre-
sented. Type 2 diabetes mellitus was the most frequent comorbidity (47.1%, 33/70). Other common comorbidities 
included cardiovascular disease (41.4%, 29/70), hypertension (34.3%, 24/70) and hyperlipidemia (31.4%, 22/70). 
Forty percent (28/70) had multiloculated liver abscesses, and the mean abscess diameter was 57.6 ± 30.6 mm.
Genotyping of clinical isolates. To identify the different capsule types among KLA strains isolated from 
these 70 patients, we genotyped the capsular polysaccharide synthesis (cps) genes via PCR-based wzy/wzx-typing 
(n = 70) and whole-genome derived wzi-typing (n = 27). The genotypic and phenotypic virulence profiles of all 
70 isolates are summarized in Table 2. Capsule types were successfully assigned for 68 isolates. No previously 
defined cps loci were detected for isolates TTSH04 and NUH11, but subsequent genomic screens indicated the 
presence of novel cps loci in both cases, which likely correspond to novel capsule types. The cps locus in TTSH04 
showed similarity to that of isolate BIDMC25 in the K. pneumoniae BIGS database (http://www.ncbi.nlm.nih.
gov/bioproject/202036). The phenotypic capsule type of BIDMC25 is unknown, and its full-length cps locus does 
not match any of those of the 79 published references9. Overall, capsule type K1 was the most common (64.3%, 
45/70), followed by K2 (20%, 14/70), K5 (5.7%, 4/70) and K57 (2.9%, 2/70). K16, K28, K63 and the two novel cps 
loci were detected in one isolate each.
We further screened isolates for possession of acquired virulence genes associated with iron metabolism 
including kfu (ferric uptake transporter), iuc (aerobactin siderophore), iro (salmochelin siderophore) and 
irp (yersiniabactin siderophore). We also screened for the three known genomic copies of rmpA (regulator of 
mucoid phenotype A; transcriptional activator of cps genes) and expression of the hypermucoviscous pheno-
type. All the K1 isolates were positive for kfu, iuc and iro, whereas 93.3% (42/45) were positive for irp. All the 
K1 isolates were hypermucoviscous, with 97.8% (44/45) harboring two copies each of rmpA while one other 
isolate had a single copy. Thirteen of these K1 isolates, including one representative irp-negative isolate, were 
selected for whole-genome sequencing (WGS), which confirmed the presence of the complete sequences of the 
virulence-related clusters detected by PCR. Subsequent in silico MLST analysis revealed that all 13 isolates repre-
sented ST23 (Supplementary Table S1). Taken together, these findings suggest that the 45 K1 isolates are closely 
related, and all are likely to represent the ST23-K1 lineage.
In contrast, there was diversity of virulence gene content among the 14 K2 isolates. Thirty-six percent (5/14) 
were positive for kfu, 64.3% (9/14) were positive for irp, 92.9% (13/14) were positive for iuc, and 100% (14/14) 
were positive for iro. While 92.9% (13/14) were hypermucoviscous, there was variation in rmpA copy number: 
35.7% (5/14), 57.1% (8/14) and 7.1% (1/14) harbored two, one and zero copies of rmpA, respectively. The one 
particular K2 isolate (named NUH04) that lacked rmpA was non-mucoviscous, consistent with rmpA regulation 
of the hypermucoviscous phenotype. Concordant with the PCR results, analysis of the whole genomes of five 
randomly selected K2 isolates showed that they each represented a distinct MLST profile (ST65, ST373, ST380, 
ST2038 and ST2039), highlighting the genotypic diversity of the K2 isolates (Supplementary Table S1). Of par-
ticular note, two of the K2-associated STs were newly identified in this study: ST2039 is the non-mucoviscous 
NUH04 strain, while ST2038 (named NUH14) is a double-locus variant of ST23. Interestingly, NUH14 was the 
only non-K1, non-ST23 isolate that tested PCR-positive for allS (activator of allantoin metabolism), which was 
carried by the other 45 K1 isolates. Therefore, NUH14 may share recent ancestry with the ST23 lineage.
We also sequenced the whole genomes of three K5 isolates, one K16 isolate, one K28 isolate, one K57 isolate 
and one K63 isolate, as well as both of the novel cps isolates. Each of these nine isolates represented a distinct 
ST, including another newly identified one, ST2037, belonging to the novel cps isolate TTSH04 (Supplementary 
Table S1). Consistent with the WGS data, PCR screening revealed diversity of virulence gene content among the 
non-K1/K2 isolates. Fifty-five percent (6/11) were positive for iuc and irp, and 63.6% (7/11) were positive for 
kfu and iro. Only 72.7% (8/11) were hypermucoviscous, and there was variation in rmpA copy number: 36.4% 
(4/11), 36.4% (4/11) and 27.3% (3/11) harbored two, one and zero copies of rmpA, respectively. The three isolates 
(K28 isolate NUH29, novel cps isolates TTSH04 and NUH11) that did not possess rmpA were non-mucoviscous, 
again consistent with rmpA regulation of the hypermucoviscous phenotype. Taken together, the non-K1 isolates 
are genetically diverse whereas the K1 isolates likely represented a single clone (ST23), consistent with previous 
studies13,15,29. Between these two distinct groups, clonal K1 isolates carried significantly higher frequencies of 
virulence-associated genes (kfu, iuc, iro, irp and rmpA) compared to non-clonal, non-K1 isolates (Fig. 1).
Resistance to human serum. The majority (90%, 63/70) of the isolates were resistant to pooled healthy 
human serum (Fig. 2a). This is generally consistent with our finding that 94.3% (66/70) of the isolates expressed 
the hypermucoviscous phenotype, which confers protection against the bactericidal effects of serum1,2,30. 
Specifically, 59/70 isolates were highly serum-resistant including one non-mucoviscous K28 strain NUH29, 4/70 
isolates were serum-resistant, 4/70 isolates were serum-susceptible, and 3/70 isolates were like the non-pathogenic 
Escherichia coli OP50 that is highly serum-susceptible. The vast majority (93.7%, 59/63) of K1/K2/K5 isolates 
were classified as either highly serum-resistant or serum-resistant, compared to only 57.1% (4/7) of non-K1/K2/
K5 isolates (P = 0.019; Fig. 2b). Amongst the non-K1/K2/K5 isolates, there was no association between virulence 
gene content and serum resistance. Therefore our data support an association between capsule types K1, K2 and 
K5 with the hypermucoviscous and serum-resistant phenotypes, which in turn are associated with increased 
virulence potential31,32.
Ethnic susceptibility to capsule types. The Chinese (n = 53) in our patient cohort had a significantly 
higher probability of infection with K1 compared to the non-Chinese (n = 17) consisting of Malays, Indian and 
Caucasian (71.7% vs 41.2%; P = 0.040; Fig. 3a). Chinese were rarely infected with the uncommon KLA cap-
sule types (i.e. non-K1/K2/K5), unlike non-Chinese who were infected with numerous non-K1/K2/K5 isolates 
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Strain name Capsule type ST HVP rmpA copy number allS kfu iuc irp iro Serum resistance grade
TTSH01 K1 NT + 2 + + + + + 5
TTSH02 K1 NT + 2 + + + + + 5
TTSH06 K1 NT + 2 + + + + + 5
TTSH07 K1 NT + 2 + + + + + 5
TTSH08 K1 NT + 2 + + + − + 5
TTSH10 K1 NT + 2 + + + + + 5
TTSH11 K1 NT + 2 + + + + + 5
TTSH12 K1 NT + 2 + + + + + 2
TTSH16 K1 NT + 2 + + + + + 5
TTSH17 K1 NT + 2 + + + + + 5
TTSH20 K1 NT + 2 + + + + + 5
TTSH23 K1 NT + 2 + + + + + 4
TTSH24 K1 NT + 2 + + + + + 5
TTSH26 K1 NT + 2 + + + + + 5
TTSH27 K1 NT + 2 + + + + + 2
NUH01 K1 23 + 2 + + + + + 4
NUH02 K1 23 + 2 + + + + + 5
NUH05 K1 NT + 2 + + + + + 5
NUH06 K1 NT + 2 + + + + + 5
NUH07 K1 NT + 2 + + + − + 5
NUH08 K1 23 + 2 + + + + + 5
NUH12 K1 NT + 2 + + + + + 5
NUH13 K1 NT + 2 + + + + + 4
NUH15 K1 23 + 2 + + + + + 5
NUH16 K1 23 + 2 + + + + + 5
NUH17 K1 23 + 2 + + + + + 5
NUH18 K1 NT + 2 + + + + + 5
NUH19 K1 23 + 2 + + + + + 5
NUH20 K1 NT + 2 + + + + + 5
NUH21 K1 NT + 2 + + + + + 5
NUH22 K1 NT + 2 + + + + + 5
NUH23 K1 23 + 2 + + + + + 5
NUH24 K1 23 + 2 + + + − + 5
NUH27 K1 23 + 2 + + + + + 2
NUH31 K1 NT + 2 + + + + + 5
NUH32 K1 NT + 2 + + + + + 5
NUH33 K1 NT + 2 + + + + + 5
NUH35 K1 NT + 1 + + + + + 5
SGH01 K1 NT + 2 + + + + + 5
SGH03 K1 NT + 2 + + + + + 5
SGH04 K1 23 + 2 + + + + + 5
SGH05 K1 23 + 2 + + + + + 5
SGH06 K1 NT + 2 + + + + + 5
SGH09 K1 NT + 2 + + + + + 5
SGH10 K1 23 + 2 + + + + + 5
TTSH03 K2 NT + 2 − − + − + 5
TTSH05 K2 373 + 1 − − − + + 5
TTSH09 K2 NT + 2 − + + + + 5
TTSH13 K2 380 + 1 − + + − + 5
TTSH14 K2 NT + 1 − + + − + 5
TTSH25 K2 NT + 1 − − + + + 5
NUH03 K2 65 + 2 − − + + + 5
NUH04 K2 2039a − 0 − − + + + 1
NUH10 K2 NT + 1 − − + + + 5
NUH14 K2 2038a + 1 + + + + + 5
NUH25 K2 NT + 2 − − + + + 5
Continued
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including K16, K28, K57, K63 and novel cps isolates (3.8% vs 29.4%; P = 0.008; Fig. 3b). While only 34% of the 
Chinese had underlying type 2 diabetes, 88.2% of the non-Chinese were diabetic (P = 0.0001; Fig. 3c). K1 strains 
are known to be capable of causing KLA in healthy individuals due to its increased virulence potential (see results 
above), whereas non-K1 strains tend to be restricted to KLA patients with predisposing conditions such as dia-
betes mellitus3. Therefore, the overrepresentation of non-K1/K2/K5 K. pneumoniae KLA among non-Chinese 
patients can in part be explained by the higher rate of diabetes within this group.
Virulence potential of K1 versus non-K1 isolates upon intraperitoneal injection into C57BL/6J 
mice. To verify that K1 isolates are more virulent than non-K1 isolates, we selected representative isolates 
for mouse infection, where variation of host susceptibility factors is significantly reduced. Two representative 
K1 strains of different phenotypic profiles were chosen: the highly serum-resistant strain SGH04 and the highly 
serum-susceptible strain NUH27. SGH04 and NUH27 are clonally related (share the same ST) and possess sim-
ilar virulence gene profiles: two copies of rmpA as well as the kfu-iuc-iro-irp clusters. In contrast, the K28 strain 
NUH29, which represents a distinct ST, lacked rmpA and the kfu-iuc-iro-irp clusters, although it was highly 
serum resistant. We chose this isolate as the representative non-K1 strain. Upon intraperitoneal injection of 104 
or 105 colony-forming units (CFUs) of SGH04 and NUH27, the majority of the mice became severely mor-
bid after 24 hours post-infection. Consistent with this clinical observation, there was comparably high bacterial 
burden in the liver, spleen and lungs of these SGH04- and NUH27-infected mice (Fig. 4). In contrast, all the 
NUH29-infected mice remained healthy and appeared to have cleared the infection at the doses of 104 and 105 
CFUs by 24 hours post-infection, since no bacterial load could be detected in their livers, spleens or lungs (Fig. 4). 
Thus, the difference in in vivo virulence between the K1 and non-K1 strains is striking, and highlights the impor-
tant roles of rmpA and the kfu-iuc-iro-irp clusters in the virulence of hvKP.
Susceptibility to extraintestinal infection upon oral inoculation of K1 into healthy control mice 
versus obese/type 2 diabetic mice. Our patient data had shown that K1 strains caused KLA in predomi-
nantly non-diabetic Chinese, suggesting inherent virulence in healthy individuals. We next investigated whether 
a K1 strain could cause similar disease in healthy mice versus a model of type 2 diabetes in mice33,34, through 
oral inoculation which represents a more natural route of infection. Mice on a high-fat diet (HFD) progressively 
gained more weight than mice on a standard chow diet (SCD) (Fig. 5a). By week 16 of diet feeding, HFD-fed mice 
were severely obese, with a mean weight 41.1% greater than SCD-fed mice (32.6 ± 3.5 vs 23.1 ± 1.3 g; P < 0.0001). 
HFD-fed mice also progressively developed glucose intolerance, as determined by oral glucose tolerance tests 
(OGTTs) performed at week 8, 12 and 16 (representative week-16 OGTT shown in Fig. 5b). By week 16, basal 
blood glucose levels were significantly higher in HFD-fed mice compared to their SCD-fed counterparts following 
6 hours of fasting (9.1 ± 0.5 vs 7.2 ± 0.2 mmol/L; P = 0.002). Upon administration of a bolus of glucose following 
the 6-hour fast, HFD-fed mice displayed impaired ability to clear glucose in the blood compared to SCD-fed mice. 
Mean peak blood glucose was reached 15 minutes after glucose challenge in both HFD-fed (19.8 ± 1.0 mmol/L) 
and SCD-fed mice (14.9 ± 0.8 mmol/L), and was completely cleared over the remaining 105 minutes in SCD-fed 
mice (7.2 ± 0.2 mmol/L) but only partially eliminated in HFD-fed mice (11.7 ± 0.7 mmol/L) (P = 0.003, when 
comparing the percentage change at 0 and 120 minutes). This marked difference in glucose tolerance between 
HFD-fed and SCD-fed mice was also apparent with the area under the curve (AUC) measurement (1719.8 ± 48.2 
vs 1165.1 ± 31.9 AUCglucose mmol/L × 120 minutes; P < 0.0001) (Fig. 5c).
Following the OGTT at week 16, the HFD-fed and SCD-fed mice were further randomized into two groups. 
One group received sterile drinking water while the other received ampicillin water for three weeks35. We chose 
SGH04 as the prototype K1 strain for the oral infection at week 19 (Fig. 5d). The incidence rate of extraintestinal 
infection, as determined by bacterial burden in the liver and spleen 72 hours post-infection, is summarized in 
Table 3. In the no antibiotic treatment group, the incidence of extraintestinal infection was slightly higher in 
Strain name Capsule type ST HVP rmpA copy number allS kfu iuc irp iro Serum resistance grade
SGH02 K2 NT + 1 − − + − + 5
SGH08 K2 NT + 1 − − + − + 5
NUH34 K2 NT + 2 − + + + + 4
TTSH15 K5 NT + 1 − + + + − 5
TTSH18 K5 828 + 2 − + + + + 5
NUH26 K5 1049 + 2 − + + + + 5
SGH07 K5 60 + 1 − + − + + 5
NUH09 K16 660 + 2 − + + + + 5
NUH29 K28 20 − 0 − − − − − 5
TTSH19 K57 NT + 2 − − + − + 5
NUH28 K57 592 + 1 − + + − + 2
NUH36 K63 111 + 1 − − − + + 5
TTSH04 Novel 2037a − 0 − + − − − 1
NUH11 Novel 399 − 0 − − − − − 1
Table 2.  Genotypic and phenotypic virulence profiles of the KLA clinical isolates (n = 70). Abbreviations: 
ST, sequence-type; NT, not tested; HVP, hypermucoviscous phenotype aNewly identified in this study
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HFD-fed (37.5%, 3/8) compared to SCD-fed mice (11.1%, 1/9), but this difference is not statistically significant 
(P = 0.294). Expectedly, ampicillin treatment significantly increased the incidence of extraintestinal infection 
as opposed to no antibiotic treatment [12/17 (70.6%) vs 4/17 (23.5%); P = 0.015]. Within the ampicillin treat-
ment group, the incidence of extraintestinal infection was also slightly higher in HFD-fed (87.5%, 7/8) com-
pared to SCD-fed mice (55.6%, 5/9). However, this difference is not statistically significant (P = 0.294). Moreover, 
once extraintestinal infection was established, the average bacterial loads in the liver or spleen were comparable 
between HFD-fed and SCD-fed mice (P = 0.755 or P > 0.999, respectively).
Figure 1. K1 isolates carried higher frequencies of virulence-associated genes than non-K1 isolates.  
These include kfu (100% vs 48%; P < 0.0001 by Fisher’s exact test), iuc (100% vs 76%; P = 0.001 by Fisher’s exact 
test), iro (100% vs 84%; P = 0.014 by Fisher’s exact test), irp (93.3% vs 60%; P = 0.001 by Fisher’s exact test)  
and rmpA (mean copy number: 1.98 vs 1.20; P < 0.0001 by Student’s t test). Expression of the hypermucoviscous 
phenotype correlated with possession of at least one rmpA copy in the genome.
Figure 2. K1/K2/K5 isolates were more resistant to serum exposure than non-K1/K2/K5 isolates.  
(a) Serum resistance level of isolates from the different capsule types. Responses were graded as follows: grade 
5 (highly serum-resistant), viable CFU after 3 hours of incubation in serum > 100% of the inoculum; grade 4 
(serum-resistant), 71– 100%; grade 2 (serum-susceptible), 1–30%; grade 1 (highly serum-susceptible), 0%. The 
negative control, E. coli OP50, was highly-serum susceptible. (b) Comparison of prevalence of serum-resistant 
(grade 4 or 5) population between K1/K2/K5 isolates and non-K1/K2/K5 isolates (93.7% vs 57.1%; P = 0.019 
using Fisher’s exact test).
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Discussion
Our study reports the association between virulence factors of hvKP and demographics and susceptibility factors 
of KLA patients. We found that the most virulent and widespread capsule type K1 infected the Chinese in our 
patient cohort at a significantly higher frequency than the non-Chinese (Malays, Indian and Caucasian). One 
plausible explanation for this finding could be that there is a higher intestinal carriage rate of capsule type K1 in 
the Chinese compared to the non-Chinese, perhaps occurring from a different environmental source of acqui-
sition. Studies in other extraintestinal pathogenic Enterobacteriaceae such as E. coli suggest that the vehicles for 
strain acquisition are probably through a combination of food, water or person-to-person transmission such as 
close contact with family members36. Indeed, one study in Japan presented evidence of familial spread of hvKP 
ST23-K1, which caused KLA in two family members at different times whereas the third member was an asymp-
tomatic carrier37. This same virulent ST23-K1 clone had been maintained among the Japanese family members 
for at least two years, supporting the concept that intestinal colonization is requisite for, but does not necessarily 
lead to clinical disease37.
Figure 3. The predominantly non-diabetic Chinese were more likely to be infected by K1 isolates and less 
likely to be infected by uncommon KLA capsule types (non-K1/K2/K5) than the predominantly diabetic 
non-Chinese. (a) Comparison of prevalence of K1 infection between Chinese and non-Chinese (71.7% vs 
41.2%; P = 0.040 by Fisher’s exact test). (b) Comparison of prevalence of non-K1/K2/K5 infection between 
Chinese and non-Chinese (3.8% vs 29.4%; P = 0.008 by Fisher’s exact test). (c) Comparison of prevalence of  
type 2 diabetes between Chinese and non-Chinese (34% vs 88.2%; P = 0.0001 by Fisher’s exact test).
Figure 4. The K1 strains SGH04 and NUH27 were more virulent than the non-K1 strain NUH29.  
Bacterial burden in the organs of mice upon intraperitoneal injection with 104 or 105 CFUs of SGH04, NUH27 
and NUH29. Each dot represents one infected mouse, whose liver, spleen and lungs were harvested 24 hours 
post-infection. Tissue homogenates that yielded no colonies were plotted with the value 10 CFU/g, which is the 
approximate limit of detection. The upper limit of quantification is 108 CFU/g.
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In South Korea, the fecal carriage rate of K. pneumoniae in healthy individuals was found to be ~21% (248 
positive stool samples out of 1,174), of which 23% were capsule type K138. In contrast, the fecal carriage rate of K. 
pneumoniae in healthy Chinese individuals in Taiwan, Hong Kong, China, Singapore, Malaysia, Japan, Thailand 
and Vietnam was found to be ~62% (592 out of 954)39. Capsule types K1/K2 accounted for ~10% in all the coun-
tries surveyed except Thailand and Vietnam, where K1-associated KLA has never been reported39. Together, these 
seroepidemiology studies imply that host genetic factors in combination with environmental factors modulate gut 
carriage of the various capsule types, to influence KLA development.
Our study also indicates that there are other factors influencing susceptibility to KLA between the various 
races beyond the dominant effect of K1 infection in Chinese. For example, Indians appear less prone to develop 
Figure 5. Incidence of extraintestinal infection was not significantly different between obese/glucose 
intolerant mice and healthy mice upon oral inoculation with hvKP K1. Data in (a–c) are means ± SEM.  
(a) Weight of mice fed a SCD or HFD over a course of 19 weeks. Ampicillin treatment between weeks 16 to 19 
did not alter body mass. (b) Plasma glucose concentrations during the OGTT following 6 hours of fasting in 
mice fed a SCD or HFD for 16 weeks. Percentage change from basal (fasting glucose level at 0 min) in SCD-
fed mice: 15 min = + 107.6% ± 10.0, 30 min = + 64.0% ± 6.3, 60 min = 26.7% ± 5.5, 120 min = + 1.1% ± 5.3. 
Percentage change from basal in HFD-fed mice: 15 min = + 121.2% ± 15.8, 30 min = + 88.8% ± 12.3, 
60 min = 54.9% ± 8.8, 120 min = + 28.5% ± 5.4. Glucose elimination is significantly faster in SCD-fed than 
HFD-fed mice (P = 0.012 and 0.003 by Student’s t test, when comparing percentage change at 0–60 minutes and 
0–120 minutes, respectively). (c) Area under the curve for glucose in (b), calculated using the trapezoidal rule. 
(d) Bacterial burden in the extraintestinal organs of SCD-fed (healthy) and HFD-fed (obese/glucose intolerant) 
mice that were treated with ampicillin or not, upon oral infection with 108 CFUs of the K1 strain SGH04. Each 
dot represents one infected mouse, whose liver and spleen were harvested 72 hours post-infection. Horizontal 
bars indicate geometric means. Tissue homogenates that yielded no colonies were plotted with the value 10 
CFU/g, which is the approximate limit of detection.
No antibiotic treatment Ampicillin treatment
SCD-fed mice 
(n = 9)
HFD-fed 
mice (n = 8) P valueb
SCD-fed mice 
(n = 9)
HFD-fed 
mice (n = 8) P valueb
Liver 1 (11.1%) 3 (37.5%) 0.294 5 (55.6%) 7 (87.5%) 0.294
Spleen 0 (0%) 0 (0%) – 3 (33.3%) 7 (87.5%) 0.050
Incidencea 1 (11.1%) 3 (37.5%) 0.294 5 (55.6%) 7 (87.5%) 0.294
Table 3.  Incidence of developing extraintestinal hvKP K1 infection in healthy control mice and obese/
glucose intolerant mice. aIncidence of extraintestinal infection was calculated as the percentage of mice that 
had positive hvKP K1 culture yielded in any of the extraintestinal organs tested. bP value was determined by 
Fisher’s exact test.
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KLA than Malays or Chinese. Although the Indian community has the highest prevalence of diabetes mellitus 
(an established risk factor for KLA) in Singapore28, the Indian race was still under-represented in KLA prevalence 
based on the population demographics. It will be informative to determine if this under-representation can be 
validated with a larger cohort, and whether it is due to differences in transmission and carriage rate, or due to host 
genetics. Therefore, it is crucial to determine the carriage of K. pneumoniae and the corresponding capsule types 
in the intestinal tracts of the various ethnic groups, particularly in Indians, Malays and Caucasians. Data on intes-
tinal carriage of K. pneumoniae in non-Chinese is currently very scarce. In addition, unique cultural practices and 
the food sources regularly consumed by each ethnic group, which is likely to influence intestinal colonization, 
need to be thoroughly examined to identify the environmental reservoir of the different typeable strains.
The Chinese in our patient cohort were mostly non-diabetic, whereas the vast majority of non-Chinese had 
underlying type 2 diabetes. Consistent with this, Fang et al. had previously reported that K1 strains are capable of 
causing KLA in healthy individuals with no significant medical histories, whereas non-K1 (particularly, non-K1/K2) 
strains tend to cause disease in patients with predisposing conditions such as diabetes mellitus3. Our mouse 
infection experiments showed that representative K1 isolates were more virulent than a representative non-K1 
isolate, similar to the findings of previous studies40. Furthermore, our genotypic data revealed that K1 isolates 
were more commonly associated with acquired virulence genes than non-K1 isolates, supporting the hypothesis 
that the former have an increased virulence potential, which presumably facilitates disease development among 
otherwise healthy individuals.
Lin et al. had reported that streptozocin-induced type 1 diabetic mice were more prone to develop extraintesti-
nal infection than naive mice upon oral infection with the K2 strain CG4341. Our diet-induced obesity-dependent 
mouse model mimics type 2 diabetes and is more representative of the clinical profile of most KLA patients. In 
our model, the incidence rate of extraintestinal infection caused by a representative K1 strain was not significantly 
higher in obese/glucose intolerant mice than in control mice. This result supports the notion that K1 isolates can 
cause KLA independent of underlying diseases in the host3, and is also consistent with our clinical finding that 
most of the K1 KLA cases occurred in Chinese patients who did not have type 2 diabetes.
In conclusion, we show that KLA infections in multi-ethnic Singapore fall into two groups: 1) genetically 
homogenous, hypervirulent K1 capsule type in non-diabetic Chinese, and 2) genetically heterogeneous non-K1 
capsule types in diabetic non-Chinese. Our work paves the way for future investigation into the unique transmis-
sion patterns and/or genetic predisposition of the various races in driving the epidemiology of KLA.
Methods
Recruitment of participants and collection of demographics and clinical information. Study 
participants were prospectively recruited as part of the A-KLASS clinical trial across three academic medical 
centers in Singapore26. Inclusion criteria include: inpatients, age ≥ 21 years, abdominal imaging suggestive of 
liver abscess and positive blood or abscess fluid culture for K. pneumoniae. Exclusion criteria include: polymicro-
bial liver abscess, endophthalmitis, central nervous system abscess or severe sepsis at the screening. Information 
collected at screening include: age, sex, ethnicity, presence of comorbidities, and results of abdominal imaging.
PCR analysis. K. pneumoniae capsule type was determined by allele-specific PCR amplification of the cps 
gene cluster at the wzy and wzx loci3; for non-discriminatory strains of wzy/wzx-typing, wzi sequencing was 
performed42. Additionally, genotyping for the presence of key virulence-associated genes including kfu, iuc, iro, 
irp, rmpA and allS was performed3,10,12. E. coli DH5α was selected as a negative control. Specific primers used to 
detect the alleles of the target gene sequences are tabulated in Supplementary Table S2.
WGS and analysis. Twenty-seven K. pneumoniae isolates were subjected to whole-genome shotgun 
sequencing on the Illumina MiSeq platform. DNA was extracted using GenElute™ bacterial genomic DNA kit 
protocol (Sigma-Aldrich). Libraries were constructed using Nextera XT kits and 150-bp sequence reads were gen-
erated. Reads were filtered to remove sequences with a mean Phred quality score < 30. Genomes were assembled 
de novo using Spades version 3.6.043. In silico MLST, wzi allele typing and virulence gene screening was performed 
using SRST244 and K. pneumoniae BIGS database (http://bigsdb.web.pasteur.fr/klebsiella/)29. Novel MLST and 
wzi allele sequences were submitted to the K. pneumoniae BIGS database for assignment of allele numbers fol-
lowing extraction from de novo assembled contigs. The wzi allele assignments were checked for associations with 
known capsule types and compared with PCR typing results. Where neither PCR typing nor wzi alleles could 
be matched to a known capsule type (n = 2), BLASTn searches were used to locate the conserved galF and ugd 
flanking genes to extract the putative capsule loci (i.e. sequence between the flanking genes) from the assemblies 
as described previously45. BLASTn searches were used to compare the relevant assembled contigs to the 79 known 
complete Klebsiella capsular locus sequences9, NCBI Genbank database and K. pneumoniae BIGS database.
String test for hypermucoviscosity. String test to determine bacterial hypermucoviscosity was performed 
as described previously5. Briefly, a bacteriologic loop was used to stretch a mucoviscous string from a second 
subculture of K. pneumoniae colony on blood agar (Sigma-Aldrich). Hypermucoviscosity is semi-quantitatively 
defined by the formation of viscous strings > 5 mm in length.
Serum resistance assays. Bacterial susceptibility to healthy pooled human serum was determined by the 
method of Podschun et al.46, with slight modifications. Briefly, bacterial strains were diluted to 1 × 106 CFU/mL 
in PBS. Next, 25 uL of bacterial suspension was added to 75 uL of pooled healthy human serum (Sigma-Aldrich). 
Viability was determined immediately and after 3 hours of incubation at 37 °C by plating out serial dilutions on 
LB agar. Responses were graded as follows: grade 5 (highly serum-resistant), viable CFU after 3 hours of incuba-
tion in serum > 100% of the inoculum; grade 4 (serum-resistant), 71–100%; grade 2 (serum-susceptible), 1–30%; 
grade 1 (highly serum-susceptible), 0%. All assays were repeated at least three times.
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Mouse model for intraperitoneal injection with K. pneumoniae. Eight-week-old C57BL/6J mice 
(n = 18) were infected with the K1 strains SGH04 and NUH27 or the K28 strain NUH29 via intraperitoneal injec-
tion at doses of 104 and 105 CFUs in 100 μ L PBS. Mice were euthanized 24 hours post-infection, and liver, spleen 
and lungs were harvested to determine bacterial burden by plating serial dilutions on HiCrome™ Klebsiella 
selective agar (Sigma-Aldrich).
Type 2 diabetes mouse model for oral infection with K. pneumoniae. Five-week-old C57BL/6 J 
mice (n = 34) were fed ad libitum with either SCD or HFD containing 35% lard (Harlan Teklad, Cat# TD.03584) 
under specific pathogen-free conditions. Following 8, 12 and 16 weeks of diet feeding, OGTTs were performed. 
After the final OGTT at week 16, the SCD-fed and HFD-fed mice were each randomized into two groups: the first 
group received normal untreated drinking water while the second group were administered with clinical-grade 
ampicillin (Sandoz, 1 g/L) in the drinking water for three weeks. Upon cessation of antibiotic treatment, mice 
were allowed to recover for 24 hours (i.e. ampicillin water replaced with normal drinking water). All 24-week-old 
mice were then orally infected with 108 CFUs of the K1 strain SGH04 in 100 μ L PBS using a 20-gauge, 38 mm 
length, flexible plastic feeding tube with soft elastomer tip (Prime Bioscience). Mice were euthanized 72 hours 
post-infection, and liver and spleen were harvested to determine bacterial burden by plating serial dilutions on 
HiCrome™ Klebsiella selective agar (Sigma-Aldrich).
OGTTs. OGTTs were performed according to the recommendations by Andrikopoulos et al.47. Briefly, mice 
were fasted for six hours prior to administration with 2 g/kg glucose into the stomach via oral gavage using a 
20-gauge, 38 mm length, flexible plastic feeding tube with soft elastomer tip (Prime Bioscience). Blood was drawn 
at 0, 15, 30, 60 and 120 minutes post glucose challenge by puncturing the lateral tail vein, and blood glucose was 
measured using Accu-Chek® Performa glucose meter and test strips (Roche).
Ethics statement. The A-KLASS protocol and the associated informed consent documents were reviewed 
and approved by National Healthcare Group Domain Specific Review Board, SingHealth Centralized Institutional 
Review Board and Health Science Authority. Study procedures were conducted in accordance with the approved 
guidelines and regulations, and written informed consent was obtained from all human participants. The animal 
protocols were reviewed, approved and carried out in strict accordance to the recommendations by Institutional 
Animal Care and Use Committee from the National University of Singapore.
Statistical analysis. Statistical tests were performed using GraphPad Prism 6, with the use of Fisher’s exact 
test for dichotomous data, Student’s t test for normally distributed continuous data and Mann-Whitney U test for 
non-normally distributed continuous data. P value of < 0.05 was considered statistically significant.
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